페인리폼 (PRFX) 주가

페인리폼(PRFX)는 NASDAQ에 상장된 Healthcare · Drug Manufacturers - Specialty & Generic 기업입니다. 현재가 $1.03 (-14.17%), 시가총액 $0.00B, 52주 범위 $0.60 ~ $3.46.

PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.

핵심 지표

• 현재가: $1.03 (-14.17%)
• 시가총액: $0.00B
• 52주 최저~최고: $0.60 ~ $3.46
• 섹터: Healthcare
• 산업: Drug Manufacturers - Specialty & Generic
• 거래소: NASDAQ

페인리폼의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

페인리폼 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 3

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 0.16
• 순이익률: 0.00%
• 영업이익률: -162.00%

자주 묻는 질문